Trial Profile
Effects of darunavir/ritonavir on cenicriviroc pharmacokinetics in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Jan 2014
Price :
$35
*
At a glance
- Drugs Cenicriviroc (Primary) ; Darunavir/ritonavir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Tobira Therapeutics
- 28 Jan 2014 New trial record